These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24415558)

  • 1. A decade of proteomics studies of glaucomatous neurodegeneration.
    Tezel G
    Proteomics Clin Appl; 2014 Apr; 8(3-4):154-67. PubMed ID: 24415558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration.
    Tezel G
    Prog Retin Eye Res; 2013 Jul; 35():18-43. PubMed ID: 23396249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of recent insights into proteomic changes associated with glaucoma.
    Funke S; Perumal N; Bell K; Pfeiffer N; Grus FH
    Expert Rev Proteomics; 2017 Apr; 14(4):311-334. PubMed ID: 28271721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Neurodegeneration in Glaucoma: Therapeutic Implications.
    Ban N; Siegfried CJ; Apte RS
    Trends Mol Med; 2018 Jan; 24(1):7-17. PubMed ID: 29233479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma.
    Yang X; Zeng Q; Barış M; Tezel G
    J Neuroinflammation; 2020 Aug; 17(1):252. PubMed ID: 32859212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex protein analysis for the study of glaucoma.
    Tezel G
    Expert Rev Proteomics; 2021 Oct; 18(10):911-924. PubMed ID: 34672220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for glaucoma: from the lab to the clinic.
    Von Thun Und Hohenstein-Blaul N; Kunst S; Pfeiffer N; Grus FH
    Eye (Lond); 2017 Feb; 31(2):225-231. PubMed ID: 28085137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent patents and developments in glaucoma biomarkers.
    Colligris B; Crooke A; Gasull X; Escribano J; Herrero-Vanrell R; Benitez-del-Castillo JM; García-Feijoo J; Pintor J
    Recent Pat Endocr Metab Immune Drug Discov; 2012 Sep; 6(3):224-34. PubMed ID: 22827637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model.
    Anders F; Teister J; Funke S; Pfeiffer N; Grus F; Solon T; Prokosch V
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1395-1407. PubMed ID: 28536832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation in Glaucoma and Optic Nerve Damage.
    Mac Nair CE; Nickells RW
    Prog Mol Biol Transl Sci; 2015; 134():343-63. PubMed ID: 26310164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of glaucomatous damage. II. Changes in the appearance of the optic disk.
    Quigley HA
    Surv Ophthalmol; 1985; 30(2):111, 117-26. PubMed ID: 4071380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma and aging.
    Guedes G; Tsai JC; Loewen NA
    Curr Aging Sci; 2011 Jul; 4(2):110-7. PubMed ID: 21235491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solving neurodegeneration: common mechanisms and strategies for new treatments.
    Wareham LK; Liddelow SA; Temple S; Benowitz LI; Di Polo A; Wellington C; Goldberg JL; He Z; Duan X; Bu G; Davis AA; Shekhar K; Torre A; Chan DC; Canto-Soler MV; Flanagan JG; Subramanian P; Rossi S; Brunner T; Bovenkamp DE; Calkins DJ
    Mol Neurodegener; 2022 Mar; 17(1):23. PubMed ID: 35313950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.
    Tezel G; Thornton IL; Tong MG; Luo C; Yang X; Cai J; Powell DW; Soltau JB; Liebmann JM; Ritch R
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8222-31. PubMed ID: 23150628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools and resources for analyzing gene expression changes in glaucomatous neurodegeneration.
    Nickells RW; Pelzel HR
    Exp Eye Res; 2015 Dec; 141():99-110. PubMed ID: 25999234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.